The Research Institute of Maternity and Child Medicine, Affiliated Shenzhen Maternity and Child Healthcare Hospital, Southern Medical University, No. 2004, Hongli Road, Futian District, Shenzhen, 518000, China.
Department of Healthcare, Affiliated Shenzhen Maternity and Child Healthcare Hospital, Southern Medical University, Shenzhen, China.
BMC Womens Health. 2022 May 14;22(1):169. doi: 10.1186/s12905-022-01728-8.
Little research has been conducted to explore variables associated with the healthcare providers' (HCPs) understanding and recommendation of human papillomavirus vaccine (HPV) since the vaccine was approved for use in China.
A large-scale cross-sectional survey was conducted in southern China covering Guangdong, Guangxi, and Hainan provinces between April 2019 and October 2019. Firstly, descriptive analysis was used to access awareness, knowledge, barriers, and recommendations toward HPV vaccine among all participants. Multi-variable logistic regression was further applied to explore potential factors associated with awareness, acknowledgment of HPV vaccine, and recommendation behaviors toward HPV vaccine.
2075 questionnaires were collected, and 2054 were included in the final analysis. In total, 77.9% of participants have heard of HPV vaccine and obtained sub-optimal HPV/HPV vaccine knowledge scores with a mean (SD) of 13.8 (3.5) out of a maximum score of 23. 68.1% HCPs reported that they have recommended HPV vaccine to others. Province and profession were the most significant characteristics associated with awareness, knowledge score, and recommendation behavior toward HPV vaccine. HCPs in Guangdong obtained a much better knowledge score [Mean (SD) = 15.5 (3.0)] and reported higher recommendation behavior (82.8%). Compare with HCPs from the Division of Expanded Program on Immunization (DEPI), Community Health Center (CHC), and obstetrician-gynecologists, other non-HPV closely related professions showed a less competent knowledge of HPV and HPV vaccine [Mean (SD) = 12.5 (3.0)] and lower frequency of recommendation behavior on vaccination (58.1%). The difference in HPV vaccine knowledge among different professions was concentrating on the items about clinical pathology of HPV and the practical aspects of HPV vaccine. Educational level and title were also closely associated with their knowledge of HPV and its vaccine. Besides, knowledge scores independently determined with recommendation behavior (OR = 1.18, 95% CI 1.13-1.23).
Knowledge level of HPV and HPV vaccine as well as recommendation behavior toward HPV vaccine were relatively lower in southern China and differed significantly between provinces. Profession-specific gaps on the knowledge level of HPV and HPV vaccine emphasized the need for targeted education and training to improve HCPs' engagement in the promotion of the HPV vaccine.
自 HPV 疫苗在中国获准使用以来,鲜有研究探索与医疗保健提供者(HCP)对 HPV 疫苗的理解和推荐相关的变量。
本研究于 2019 年 4 月至 10 月在广东、广西和海南三省进行了一项大规模的横断面调查。首先,采用描述性分析评估所有参与者对 HPV 疫苗的知晓率、知识水平、障碍因素和推荐意向。进一步采用多变量逻辑回归分析探索与知晓率、对 HPV 疫苗的认知以及推荐 HPV 疫苗行为相关的潜在因素。
共收集 2075 份问卷,其中 2054 份纳入最终分析。总体而言,77.9%的参与者听说过 HPV 疫苗,但 HPV/HPV 疫苗知识得分较低,满分为 23 分,平均得分为 13.8(3.5)。68.1%的 HCP 曾向他人推荐 HPV 疫苗。省份和职业是与 HPV 疫苗知晓率、知识得分和推荐行为最显著相关的特征。来自广东的 HCP 获得了更好的知识得分[均值(SD)=15.5(3.0)],报告的推荐行为更高(82.8%)。与来自扩大免疫规划司(DEPI)、社区卫生中心(CHC)和妇产科的 HCP 相比,其他非 HPV 密切相关的专业对 HPV 和 HPV 疫苗的知识水平较低[均值(SD)=12.5(3.0)],推荐疫苗接种的频率较低(58.1%)。不同专业之间 HPV 疫苗知识的差异集中在 HPV 的临床病理学和 HPV 疫苗的实际应用方面。教育水平和职称也与 HPV 及其疫苗的知识密切相关。此外,知识得分独立决定了推荐行为(OR=1.18,95%CI 1.13-1.23)。
中国南方地区 HPV 和 HPV 疫苗的知识水平以及对 HPV 疫苗的推荐行为相对较低,且各省份之间存在显著差异。HPV 和 HPV 疫苗知识方面的专业差异强调了需要进行针对性教育和培训,以提高 HCP 对 HPV 疫苗的推广参与度。